Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India launches major nanotech programme:

This article was originally published in Clinica

Executive Summary

India is reportedly planning to invest Rs1,000 crore ($229m) to the Indian Institute of Science to fund a five-year nanotech manufacturing programme. One technology mooted to receive funds is a synchrotron facility, which produces X-rays and other radiation. The "national mission on nano science and nano technology" has been launched by the department of science and technology (DST), which has spent between Rs20m-30m per year for the past three years on fostering research in nanotechnology. The Hindu reports that the pledge follows a grant of Rs100 crore to make the institute a world class institution.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel